Clinical trial
Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder
NCT02557971 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2015
- Completion date
- July 31, 2016
- Enrollment
- 315 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.